Cancer in Fanconi Anemia: A Clinical Overview
Dr. Jennifer Grandis (University of California, San Francisco) gives a clinical overview of cancer in Fanconi anemia patients, delivered at the 2023 FA Scientific Symposium.
Resource Library
- All Categories
- BRCA1
- Disability
- FARF
- GvHD
- Lesions
- SSI
- Tumor
- Diagnosis
- BRCA2
- DNA
- Fertility
- Haploidentical
- Maladie de Fanconi
- Private Health Insurance
- Vaccine
- Breast Cancer
- DNA Repair
- Finances & Insurance
- Head and neck
- Medicaid
- Psychological
- Stem Cell Donor
- Vulvar Cancer
- Transplant
- BRIP1
- Donor
- Financial Support
- Healthcare
- Medicare
- Psychosocial Support
- Stem cells
- Waivers
- Cancer
- Cancer Risk
- Endocrine
- FMLA
- Health Insurance
- Mental Health
- Recursos en español
- Steroids
- Wellbeing
- Finances
- Caregiver Resources
- Endocrinologist
- Food
- Help
- Monitoring
- Research
- Wellness
- Case management
- Endocrinology
- Français
- Hematology
- Newly diagnosed
- Resilience
- Success Rates
- What is FA
- Caregivers
- Chemotherapy
- Esophagus
- Fundraising
- Hematopoietic
- Nutrition
- Resources
- Sun
- Clinical Trials
- Español
- Gastrointestinal
- hereditary
- Oral Cancer
- Science
- Sunscreen
- Acute Myeloid Leukemia
- Comprehensive Care Center
- FA Basics
- Gene
- HLA Matching
- PALB2
- Screening
- Support
- Adults
- Coping
- Family
- HNSCC
- Pathway
- Siblings
- Support group
- Allogeneic
- Counseling
- Family Planning
- Gene Therapy
- Hormones
- Skin
- Symptoms
- Anemia de Fanconi
- Covid-19
- FANC-A
- Genetic
- Infertility
- Peer Support
- Skin Cancer
- Transplant Center
- Anogenital
- FANCJ
- Inheritance
- PGD
- Social Security Disability Insurance
- Transplant Resources
- Bone Marrow
- Dermatology
- FANCN
- Growth
- Insurance
- PGT
- Squamous Cell Carcinoma
- Trauma
- Bone marrow failure
- Diet
- FANCO
- Growth Curve
- IVF
- Post transplant
- SSDI
- Treatment
“Power to U”: New campaign to manage the increased risk for oral cancer
We focus on early detection by providing all different kinds of support (including clinicians and individuals with FA)
The Future of FA Cancer Research: The Fanconi Anemia Cancer Consortium
FARF Scientific Director, Isis Sroka, talks about the newly developed Fanconi Anemia Cancer Consortium (FACC).
The NIH Center Comprehensive Program for Surveillance of Squamous Cell Carcinoma in Patients with FA
Neelam Giri and Sharon Savage cover a brief description of the protocol to prospectively evaluate and follow patients with FA at high risk of SCC with screening at regular intervals.
FARF Clinical Programs: Virtual Tumor Board & FA Registry
FARF's Clinical Science Program Manager, Andrea Ronan, gives an overview of the FARF clinical programs, including the Fanconi Anemia Registry and Virtual Tumor Board.
Let’s Talk About Cancer in FA
A visual overview sheet about cancer in FA: the basics and what you need to know.